Telesis Bio Inc (TBIO)
0.3235
+0.01
(+2.63%)
USD |
NASDAQ |
Apr 23, 16:00
0.3235
0.00 (0.00%)
After-Hours: 19:40
Telesis Bio Cash from Financing (TTM): 11.56M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.56M |
September 30, 2023 | 26.69M |
June 30, 2023 | 30.81M |
March 31, 2023 | 4.434M |
December 31, 2022 | 4.51M |
September 30, 2022 | 4.387M |
June 30, 2022 | -0.611M |
Date | Value |
---|---|
March 31, 2022 | 111.55M |
December 31, 2021 | 121.08M |
September 30, 2021 | 121.08M |
June 30, 2021 | 122.04M |
March 31, 2021 | 9.518M |
December 31, 2020 | -0.096M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.611M
Minimum
Jun 2022
122.04M
Maximum
Jun 2021
43.61M
Average
11.56M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
Ainos Inc | 4.924M |
OpGen Inc | 7.287M |
Zomedica Corp | -- |
LENSAR Inc | -- |
Eargo Inc (DELISTED) | 33.86M |